Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats
Open Access
- 1 February 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (3) , 640
Abstract
Atypical antipsychotics, such as olanzapine, are commonly prescribed to patients with schizophrenic symptoms and other psychiatric disorders. However, weight gain and metabolic disturbance cause adverse effects, impair patient compliance and limit clinical utility. Thus, a better understanding of treatment-acquired adverse effects and identification of targets for therapeutic intervention are believed to offer more clinical benefits for patients with schizophrenia. Beyond its nutritional effects, studies have indicated that supplementation of chromium brings about beneficial outcomes against numerous metabolic disorders. In this study, we investigated whether olanzapine-induced weight gain and metabolic disturbance involved chromium dynamic mobilization in a female Sprague-Dawley rat model, and whether a dietary supplement of chromium improved olanzapine-acquired adverse effects. Olanzapine medicated rats experienced weight gain and adiposity, as well as the development of hyperglycemia, hyperinsulinemia, insulin resistance, hyperlipidemia, and inflammation. The olanzapine-induced metabolic disturbance was accompanied by a decrease in hepatic Akt and AMP-activated Protein Kinase (AMPK) actions, as well as an increase in serum interleukin-6 (IL-6), along with tissue chromium depletion. A daily intake of chromium supplements increased tissue chromium levels and thermogenic uncoupling protein-1 (UCP-1) expression in white adipose tissues, as well as improved both post-olanzapine weight gain and metabolic disturbance. Our findings suggest that olanzapine medicated rats showed a disturbance of tissue chromium homeostasis by inducing tissue depletion and urinary excretion. This loss may be an alternative mechanism responsible for olanzapine-induced weight gain and metabolic disturbance.Keywords
This publication has 49 references indexed in Scilit:
- Effects of Antipsychotic Medications on Appetite, Weight, and Insulin ResistanceEndocrinology and Metabolism Clinics of North America, 2013
- Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ miceBiochemical and Biophysical Research Communications, 2010
- Chronic Maternal Dietary Chromium Restriction Modulates Visceral AdiposityDiabetes, 2009
- Chromium attenuates hepatic damage in a rat model of chronic cholestasisLife Sciences, 2009
- Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic miceDiabetes, Obesity and Metabolism, 2009
- Chromium supplementation improves glucose tolerance in diabetic Goto‐Kakizaki ratsIUBMB Life, 2008
- Effect of Chromium Supplementation on Glucose Metabolism and LipidsDiabetes Care, 2007
- Second-Generation (Atypical) Antipsychotics and Metabolic EffectsCNS Drugs, 2005
- Concentrations of Seven Trace Elements in Different Hematological Matrices in Patients with Type 2 Diabetes as Compared to Healthy ControlsBiological Trace Element Research, 2001
- Effects of carbohydrate loading and underwater exercise on circulating cortisol, insulin and urinary losses of chromium and zincEuropean Journal of Applied Physiology, 1991